|
RBM12B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.257000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.559400E-03 |
| Normal-vs-Stage2 |
2.539600E-01 |
| Normal-vs-Stage3 |
1.041580E-03 |
| Normal-vs-Stage4 |
2.262300E-03 |
| Stage1-vs-Stage2 |
5.799600E-01 |
| Stage1-vs-Stage3 |
1.616220E-01 |
| Stage1-vs-Stage4 |
2.585000E-01 |
| Stage2-vs-Stage3 |
2.034400E-01 |
| Stage2-vs-Stage4 |
2.372200E-01 |
| Stage3-vs-Stage4 |
9.171200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.659600E-03 |
| Normal-vs-AfricanAmerican |
5.903800E-03 |
| Normal-vs-Asian |
9.840200E-01 |
| Caucasian-vs-AfricanAmerican |
4.834000E-01 |
| Caucasian-vs-Asian |
2.675000E-01 |
| AfricanAmerican-vs-Asian |
1.328830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.423590E-03 |
| Normal-vs-Female |
2.303900E-02 |
| Male-vs-Female |
1.514780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.405900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.979700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.019420E-03 |
| Normal-vs-Age(81-100Yrs) |
2.129800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.953000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.215200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.577200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.035800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.505600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.643800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.468400E-01 |
| Normal-vs-Grade 2 |
9.095900E-02 |
| Normal-vs-Grade 3 |
1.262650E-03 |
| Normal-vs-Grade 4 |
3.75169999999869E-05 |
| Grade 1-vs-Grade 2 |
3.063800E-01 |
| Grade 1-vs-Grade 3 |
2.687700E-02 |
| Grade 1-vs-Grade 4 |
4.819700E-03 |
| Grade 2-vs-Grade 3 |
3.134400E-02 |
| Grade 2-vs-Grade 4 |
7.971200E-04 |
| Grade 3-vs-Grade 4 |
5.023900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.904400E-02 |
| Normal-vs-ccB subtype |
3.080500E-03 |
| ccA subtype-vs-ccB subtype |
7.152200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.609760E-02 |
| Normal-vs-N1 |
3.776100E-02 |
| N0-vs-N1 |
3.319200E-01 |
|
|
